CE-IVD test provides tool for clinical diagnosis of Coronavirus (COVID-19).
Key Benifits:
- Rapid detection of COVID-19
- Highly specific detection profile
- High priming efficiency
- Accurate controls to confirm extraction, run and reaction validity
- Supplied lyophilised with no cold chain shipping
- Validated against nasopharyngeal and oropharyngeal swabs as well as sputum
- Multi Platform Capability
Kit Includes:
- Primer & Probe Mix
- Positive Control Template
- Internal Extraction Control
- DNase/RNase free water
- Oasig Lyophilised qPCR Master Mix
genesig® Real-Time PCR Coronavirus (COVID-2019) CE This new molecular kit has been developed for the clinical diagnosis of COVID-19. RNA extracted from patient samples can then be analysed using the genesig Coronavirus (COVID-19) CE IVD test (validated against ABI 7500 [Applied Biosystems], CFX [Bio-Rad] and LC480 [Roche]). The detection profile of the kit displays zero cross reactivity with other related viruses and 100% homology with all published SARS-CoV-2 sequences. Our COVID-19 CE IVD kit with lyophilised reagents is available with NO cold chain shipping globally. This is the ultimate solution to sensitive, rapid and cost-effective clinical diagnosis of COVID-19
Kit controls and standards The kit includes an Internal Control to identify possible PCR inhibition, to measure extraction purity and to confirm the integrity of PCR run. Our CE kits come combined with Oasig™ Lyophillised Master Mix providing a complete one kit diagnostic system.
No data available.